AMI    Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet (2004);364:937-52 S. Yusuf, et al. Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry) Am J Cardiol (2004);93:1543-6 H. Wienbergen, et al. Hyperbaric oxygen treatment does not affect left ventricular chamber stiffness after myocardial infarction treated with thrombolysis Am Heart J (2004);148:e1 A. Vlahovic, et al. Detection of increased temperature of the culprit lesion after recent myocardial infarction: the favorable effect of statins Am Heart J (2004);148:783-8 K. Toutouzas, et al. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial Am Heart J (2004);148:e2 P. L. Thompson, et al. Circadian variation of plaque rupture in acute myocardial infarction Am J Cardiol (2004);93:1-5 A. Tanaka, et al. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy J Am Coll Cardiol (2004);44:38-43 T. Taher, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis Circulation (2004);110:1387-91 S. Suzuki, et al. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block Circulation (2004);110:1896-902 U. Stenestrand, et al. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol (2004);43:549-56 M. T. Roe, et al. Obesity and the risk of death after acute myocardial infarction Am Heart J (2004);147:841-6 J. S. Rana, et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy Am Heart J (2004);148:e3 J. Pache, et al. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction Am Heart J (2004);147:897-904 K. Middendorf, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial Jama (2005);293:437-46 S. R. Mehta, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy J Am Coll Cardiol (2004);44:335-9 J. L. Mega, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation (2004);109:3171-5 S. Matetzky, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction J Am Coll Cardiol (2004);44:1510-20 Y. Maekawa, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol (2004);43:704-8 P. A. Lemos, et al. Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography Am Heart J (2004);147:281-6 S. G. Lee, et al. Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion Circulation (2004);110:e533-9 M. W. Krucoff, et al. Effects of percutaneous coronary arterial thrombectomy during acute myocardial infarction on left ventricular remodeling Am J Cardiol (2004);93:527-31 H. Kondo, et al. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol (2004);44:276-86 R. A. Kloner and S. H. Rezkalla Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Cardiol (2005);95:337-42 A. J. Kirtane, et al. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Circulation (2004);110:1754-60 P. Kaul, et al. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials Am Heart J (2004);147:457-62 D. E. Kandzari, et al. Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers Am J Cardiol (2004);94:632-6, A9 H. J. Jaatun, et al. Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure Am J Cardiol (2004);93:603-6 A. Hognestad, et al. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study Eur Heart J (2004);25:232-9 J. Herlitz, et al. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry Heart (2004);90:1404-10 G. Hanania, et al. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction Am Heart J (2004);147:158-64 M. Gyongyosi, et al. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial J Am Coll Cardiol (2004);43:542-8 H. S. Gurm, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study Lancet (2005);365:475-81 D. J. Graham, et al. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol (2004);44:980-7 C. M. Gibson, et al. Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction J Am Coll Cardiol (2004);43:1170-6 C. M. Gibson, et al. Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction Am Heart J (2004);147:847-52 C. M. Gibson, et al. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction Am J Cardiol (2004);94:108-11 C. M. Gibson, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation (2004);110:1392-7 M. Frossard, et al. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study Am Heart J (2004);148:306-11 B. Frilling, et al. Value of electrocardiographic algorithm based on "ups and downs" of ST in assessment of a culprit artery in evolving inferior wall acute myocardial infarction Am J Cardiol (2004);94:709-14 M. Fiol, et al. Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size J Am Coll Cardiol (2004);43:2124-31 D. S. Fieno, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial Lancet (2004);364:1045-53 F. Fernandez-Aviles, et al. Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI) Am Heart J (2004);148:378-85 C. Di Mario, et al. Adjunctive effect of hyperbaric oxygen treatment after thrombolysis on left ventricular function in patients with acute myocardial infarction Am Heart J (2004);148:E14 M. Dekleva, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation (2004);109:1223-5 G. De Luca, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry Circulation (2004);110:1909-15 N. Danchin, et al. Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel J Am Coll Cardiol (2004);43:162-8 M. Dalby, et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction Am Heart J (2004);148:493-500 R. A. Corpus, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction Am J Cardiol (2004);94:9-13 M. J. Claeys, et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction Am J Cardiol (2005);95:349-54 L. Y. Chen, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction Circulation (2004);109:849-54 A. Chaudhuri, et al. Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction Am J Cardiol (2004);93:1465-8 A. S. Binbrek, et al. Long-term prognostic significance of left atrial volume in acute myocardial infarction J Am Coll Cardiol (2004);44:327-34 R. Beinart, et al. Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction Am J Cardiol (2004);94:415-20 J. Avorn, et al. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone Circulation (2004);109:1704-6 D. Antoniucci, et al. Pharmacoinvasive therapy: the future of treatment for ST-elevation myocardial infarction Circulation (2004);109:2480-6 E. M. Antman and F. Van de Werf ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Managem J Am Coll Cardiol (2004);44:E1-E211 E. M. Antman, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Circulation (2004);110:588-636 E. M. Antman, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Managem Circulation (2004);110:e82-292 E. M. Antman, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 J Am Coll Cardiol (2004);44:671-719 E. M. Antman, et al. Classification of systemic therapies for potential stabilization of the vulnerable plaque to prevent acute myocardial infarction Am J Cardiol (2005);95:379-82 J. A. Ambrose and D. J. D'Agate Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial Circulation (2004);110:1572-8 D. Aguilar, et al. Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy Am J Cardiol (2004);94:337-9 D. Aguilar, et al.